Loss of heterozygosity and methylation of p16 in renal cell carcinoma

被引:24
|
作者
Sanz-Casla, MT
Maestro, ML
del Barco, V
Zanna, I
Moreno, J
Vidaurreta, M
Almansa, I
Fernández, C
Blanco, J
Maestro, C [1 ]
Resel, L
机构
[1] Hosp Clin San Carlos, Lab, Dept Tumor Biol, Madrid 28040, Spain
[2] Hosp Clin San Carlos, Dept Urol, Madrid 28040, Spain
[3] Hosp Clin San Carlos, Dept Pathol, Madrid 28040, Spain
[4] Hosp Clin San Carlos, Dept Epidemiol, Madrid 28040, Spain
[5] Univ Complutense, Dept Mophol Sci, E-28040 Madrid, Spain
来源
UROLOGICAL RESEARCH | 2003年 / 31卷 / 03期
关键词
loss of heterozygosity; methylation; p16; gene; renal cell carcinoma;
D O I
10.1007/s00240-003-0308-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To investigate the possible role of genomic aberrations of chromosome 9p21 in the tumorigenesis of human renal cell carcinoma (RCC), 40 sporadic RCCs were studied using PCR analyses. The tumours were predominantly low stage and low grade. Loss of heterozygosity (LOH) was observed in nine of 39 informative cases, but no homozygous deletion was noticed. Hypermethylation of the promoter region of p16 occurred in eight of the 40 RCCs. No correlation was found between hypermethylation of the p16 gene and LOH on 9p21. A similar level of LOH and methylation was observed in the 40 RCCS regardless of histology, grade and stage. These results suggest that inactivation of p16 and the possibility of other unknown tumour suppresser genes located on other chromosomes could be involved in the pathogenesis of RCC.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 50 条
  • [21] p16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma
    Nakayama, Goro
    Hibi, Kenji
    Kodera, Yasuhiro
    Koike, Masahiko
    Fujiwara, Michitaka
    Nakao, Akimasa
    [J]. ANTICANCER RESEARCH, 2007, 27 (5A) : 3367 - 3370
  • [22] High frequency of simultaneous loss of p16 and p16 beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach
    Hayashi, K
    Metzger, R
    Salonga, D
    Danenberg, K
    Leichman, LP
    Fink, U
    Sendler, A
    Kelsen, D
    Schwartz, GK
    Groshen, S
    Lenz, HJ
    Danenberg, PV
    [J]. ONCOGENE, 1997, 15 (12) : 1481 - 1488
  • [23] Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck
    Gonzalez, MV
    Pello, MF
    LopezLarrea, C
    Suarez, C
    Menendez, MJ
    Coto, E
    [J]. CLINICAL CANCER RESEARCH, 1995, 1 (09) : 1043 - 1049
  • [24] METHYLATION AND P16 - SUPPRESSING THE SUPPRESSOR
    LITTLE, M
    WAINWRIGHT, B
    [J]. NATURE MEDICINE, 1995, 1 (07) : 633 - 634
  • [25] p16 is expressed in ovarian clear cell carcinoma
    Adeniran, A. J.
    Euscher, E. D.
    Deavers, M. T.
    Malpica, A.
    [J]. MODERN PATHOLOGY, 2007, 20 : 186A - 186A
  • [26] p16 is expressed in ovarian clear cell carcinoma
    Adeniran, A. J.
    Euscher, E. D.
    Deavers, M. T.
    Malpica, A.
    [J]. LABORATORY INVESTIGATION, 2007, 87 : 186A - 186A
  • [27] P16 Expression Differentiates Merkel Cell Carcinoma
    Carrigg, A. B.
    Zhang, H.
    Liu, Y-T
    Wang-Rodriguez, J.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 114A - 114A
  • [28] p16 gene expression in basal cell carcinoma
    Eshkoor, Sima Ataollahi
    Ismail, Patimah
    Rahman, Sabariah Abdul
    Oshkour, Soraya Ataollahi
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (07) : 668 - 673
  • [29] P16 Expression Differentiates Merkel Cell Carcinoma
    Carrigg, A. B.
    Zhang, H.
    Liu, Y-T
    Wang-Rodriguez, J.
    [J]. MODERN PATHOLOGY, 2011, 24 : 114A - 114A
  • [30] Aberrant p16 Methylation, a Possible Epigenetic Risk Factor in Familial Esophageal Squamous Cell Carcinoma
    Abbaszadegan, Mohammad Reza
    Raziee, Hamid Reza
    Ghafarzadegan, Kamran
    Shakeri, Mohammad Taghi
    Afsharnezhad, Sima
    Ghavamnasiry, Mohammad Reza
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2005, 36 (01) : 47 - 53